Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Vinod Thourani

September 28, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Presenter: Martin Leon

September 26, 2019

Presentation TCT 2019

Complex CLI Case Review 3: What Is Possible in the OBL?

Presenter: Eric Dippel

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: BEST-CLI, BASIL-2 and BASIL-3

Presenter: Matthew Menard

September 25, 2019

Presentation TCT 2019

CTO Crossing 3: Case Examples of Antegrade Access and Closure

Presenter: Craig Walker

September 25, 2019

Presentation TVT 2019

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Presenter: Philippe Pibarot

June 14, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

Highlights From the PARTNER 3 Low-Risk Trial

Presenter: Michael Mack

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Presentation CIT 2019

PARTNER 3 and TAVR Trials

Presenter: Rebecca T. Hahn

March 28, 2019

Presentation SIF 2019

Top 4 Structural Trials of the Last Year

Presenter: Michael J Reardon

March 27, 2019

Presentation ACC 2019

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Presenter: Martin B. Leon

March 17, 2019

Advertisement

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Complex CLI Case Review 3: What Is Possible in the OBL?

Clinical Trial Updates: BEST-CLI, BASIL-2 and BASIL-3

CTO Crossing 3: Case Examples of Antegrade Access and Closure

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Highlights From the PARTNER 3 Low-Risk Trial

The PARTNER 3 Low-Risk Randomized Trial

PARTNER 3 and TAVR Trials

Top 4 Structural Trials of the Last Year

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content